Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

Open Access 01-04-2021 | Original Article

Laboratory evaluation of the Sigma Transwab® transport system for the recovery of Candida species using the Clinical and Laboratory Standards Institute (CLSI) document M40-A2

Authors: E. Elcocks, E.C. Adukwu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2021

Abstract

Rising healthcare complications due to fungal infections increase the importance of efficient specimen collection and maintenance systems for correct identification and diagnosis. The CLSI M40-A2 protocol provides guidelines for laboratories assessing quality of medical transport devices, including swab transport systems (STS). This study assessed the efficiency of the Sigma Transwab® foam and flock swab in recovering and maintaining viability of different Candida spp. including C. auris, in different test conditions. Both swab types recovered and maintained viability of all Candida spp. with greater CFU at room temperature after incubation (24 and 48 h) in comparison with swabs maintained at 4 °C.

Fisher MC, Gurr SJ, Cuomo CA, Blehert DS, Jin H, Stukenbrock EH, Stajich JE, Kahmann R, Boone C, Denning DW, Gow NAR, Klein BS, Kronstad JW, Sheppard DC, Taylor JW, Wright GD, Heitman J, Casadevall A, Cowen LE (2020) Threats posed by the fungal kingdom to humans, wildlife, and agriculture. mBio 11:e00449–e00420. https://doi.org/10.1128/mBio.00449-20CrossRefPubMedPubMedCentral

Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216:S445–S451. https://doi.org/10.1093/infdis/jix131CrossRefPubMed

Vecchione A, Florio W, Celandroni F et al (2017) Comparative evaluation of six chromogenic media for presumptive yeast identification. J Clin Pathol 70:1074–1078. https://doi.org/10.1136/jclinpath-2017-204396CrossRefPubMed

Satoh K, Makimura K, Hasumi Y et al (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41–44. https://doi.org/10.1111/j.1348-0421.2008.00083.xCrossRefPubMed

Lockhart SR, Etienne KA, Vallabhaneni S et al (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134–140. https://doi.org/10.1093/cid/ciw691CrossRefPubMed

Kathuria S, Singh PK, Sharma C et al (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization–time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53:1823–1830. https://doi.org/10.1128/JCM.00367-15CrossRefPubMedPubMedCentral

Lockhart SR, Jackson BR, Vallabhaneni S et al (2017) Thinking beyond the common Candida species: need for speciation of Candida due to the emergence of multidrug resistant Candida auris. J Clin Microbiol 55:JCM.01355–JCM.01317. https://doi.org/10.1128/JCM.01355-17CrossRef

Lockhart SR, Berkow EL, Chow N et al (2017) Candida auris for the clinical microbiology laboratory: not your grandfather’s Candida species. Clin Microbiol Newsl 39:99–103. https://doi.org/10.1016/j.clinmicnews.2017.06.003CrossRefPubMedPubMedCentral

Kordalewska M (2017) Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen. Candida auris 55:2445–2452

10.

Sarma S, Upadhyay S (2017) Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist 10:155–165. https://doi.org/10.2147/IDR.S116229CrossRefPubMedPubMedCentral

11.

Tsay S, Kallen A, Jackson BR et al (2018) Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast. Clin Infect Dis 66:306–311. https://doi.org/10.1093/cid/cix744CrossRefPubMedPubMedCentral

12.

Sears D, Schwartz BS (2017) Candida auris: an emerging multidrug-resistant pathogen. Int J Infect Dis 63:95–98. https://doi.org/10.1016/j.ijid.2017.08.017CrossRefPubMed

13.

Chowdhary A, Voss A, Meis JF (2016) Multidrug-resistant Candida auris: ‘new kid on the block’ in hospital-associated infections? J Hosp Infect 94:209–212. https://doi.org/10.1016/j.jhin.2016.08.004CrossRefPubMed

14.

Gizzie N, Adukwu E (2016) Evaluation of liquid-based swab transport systems against the new approved CLSI M40-A2 standard. J Clin Microbiol 54:1152–1156. https://doi.org/10.1128/JCM.03337-15CrossRefPubMedPubMedCentral

15.

Clinical and Laboratory Standards Institute C. M40-A2: quality control of microbiological transport systems; Approved Standard - Second Edition. Clin Lab Stand Inst Published Online First:2014.https://clsi.org/media/1453/m40a2_sample.pdf (accessed 10 May 2018)

16.

Scansen KA, Bonsu BK, Stoner E et al (2010) Comparison of polyurethane foam to nylon flocked swabs for collection of secretions from the anterior nares in performance of a rapid influenza virus antigen test in a pediatric emergency department. J Clin Microbiol 48:852–856. https://doi.org/10.1128/JCM.01897-09CrossRefPubMed

17.

Gandhi B, Summerbell R, Mazzulli T (2018) Evaluation of the Copan ESwab transport system for viability of pathogenic fungi by use of a modification of Clinical and Laboratory Standards Institute document M40-A2. J Clin Microbiol 2018:56(2)

18.

Griffin DM (1985) A comparison of the roles of Bacteria and Fungi. In: Leadbetter ER, Poindexter JS (eds) Bacteria in nature, vol 1. Springer, Boston. https://doi.org/10.1007/978-1-4615-6511-6_8CrossRef

19.

Moore V.L. (2009) Microbiology basics. APIC Text of Infection Control & Epidemiology, 3rd edition. http://eta.health.usf.edu/publichealth/PHC6562/Midterm_Final_ExtraCredit_pools/HO1_Microbiology_Basics_APIC_Chapter16.pdf

Title: Laboratory evaluation of the Sigma Transwab® transport system for the recovery of Candida species using the Clinical and Laboratory Standards Institute (CLSI) document M40-A2
Authors: E. Elcocks
E.C. Adukwu
Publication date: 01-04-2021
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-04062-9

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2021

Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19

Prediction of antimicrobial resistance in clinical Campylobacter jejuni isolates from whole-genome sequencing data

Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship

Rapid detection of antimicrobial resistance markers with Allplex™ Entero-DR assay directly from positive blood culture bottles

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2

High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage